Cartherics and ToolGen sign a deal on CAR-T therapy
24 January, 2019Australia's Cartherics and Seoul-based ToolGen have teamed up to bring innovative immunotherapies for cancer a step closer to reality.
Solving the genetics puzzle
07 January, 2019 by Mansi GandhiGrowing up in Germany, Melanie Bahlo used to record which birds came and visited her bird feeder in the depths of winter. She was around eight years old at the time and loved discovering new things.
Cannabis-based drug relieves symptoms of motor neuron disease
18 December, 2018Chemical compounds derived from the cannabis sativa plant, used as an add-on treatment, may help ease symptoms of spasticity in people with motor neuron disease.
Brain-stimulation implant could treat epilepsy patients
04 December, 2018A tiny device that electrically stimulates the brain could one day be used to treat conditions such as epilepsy and Parkinson's disease — without open-brain surgery.
Roadmap released for regenerative medicine sector
28 November, 2018MTPConnect's report 'Regenerative Medicine: Opportunities for Australia' provides a roadmap for elevating the sector so it can successfully compete at a global level.
Cannabis compound may benefit children with epilepsy
27 November, 2018Researchers reviewing studies around the medical use of cannabidiol have found the treatment to be moderately effective in two forms of childhood epilepsy.
Immunotherapy trial for MS shows early positive results
21 November, 2018A new cellular immunotherapy treatment that targets the Epstein-Barr virus (EBV) has been found to improve multiple sclerosis (MS) symptoms.
LogicBio, CMRI partner to develop next-gen viral vectors
19 November, 2018Genome editing company LogicBio has partnered with the Children's Medical Research Institute to fast-track gene therapy treatments for children with life-threatening genetic liver disease.
Online tool predicts how cells repair broken DNA
19 November, 2018Researchers have created a machine learning model, inDelphi, that predicts how human and mouse cells respond to CRISPR-induced breaks in DNA.
AusCann set to launch cannabinoid medicine for chronic pain
15 November, 2018AusCann's hard-shell capsules will target the estimated 1.9 million Australians who suffer chronic neuropathic pain.
Liver fluke key to chronic wound treatment
08 November, 2018Researchers have developed a promising new treatment for chronic wounds, utilising a protein isolated from a surprising source — a parasitic Thai liver fluke.
Collaboration to accelerate early-stage drug discovery
07 November, 2018Biomedical research company BioCurate and pharmaceutical company Novartis have announced they will collaborate on early-stage drug discovery projects.
Plant peptide shows promise in antifungal trial
05 November, 2018Biotechnology company Hexima has announced promising results for its plant defensin peptide, HXP124, in fungal nail infections.
100% human skin graft developed
01 November, 2018Researchers have made a skin graft cell culture using only human cells, which could be used to provide safer treatment for severe burns and other skin conditions in the future.
New PBS listings benefit lung cancer, cholesterol patients
30 October, 2018Two new listings on the Pharmaceutical Benefits Scheme have the potential to extend the lives of Australians with advanced lung cancer and those at risk of a heart attack.
